BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 9514872)

  • 1. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    J Rheumatol; 1998 Dec; 25(12):2440-4. PubMed ID: 9858442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    Rheumatology (Oxford); 1999 Dec; 38(12):1275-8. PubMed ID: 10587559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.
    Hein GE; Köhler M; Oelzner P; Stein G; Franke S
    Rheumatol Int; 2005 Dec; 26(2):137-41. PubMed ID: 15580352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
    Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
    Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.
    Senolt L; Braun M; Vencovský J; Sedová L; Pavelka K
    Physiol Res; 2007; 56(6):771-777. PubMed ID: 17298211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
    DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
    Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis.
    Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    Br J Rheumatol; 1997 Jun; 36(6):637-42. PubMed ID: 9236672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis.
    Ibrahim SM; Hamdy MS; Amer N
    Egypt J Immunol; 2008; 15(1):159-70. PubMed ID: 20306680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentrations of serum pentosidine in rheumatoid arthritis.
    Rodríguez-García J; Requena JR; Rodríguez-Segade S
    Clin Chem; 1998 Feb; 44(2):250-5. PubMed ID: 9474020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
    Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
    Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.
    Kageyama Y; Takahashi M; Nagafusa T; Torikai E; Nagano A
    Rheumatol Int; 2008 Jan; 28(3):245-51. PubMed ID: 17661050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced carbonyl stress in a subpopulation of schizophrenia.
    Arai M; Yuzawa H; Nohara I; Ohnishi T; Obata N; Iwayama Y; Haga S; Toyota T; Ujike H; Arai M; Ichikawa T; Nishida A; Tanaka Y; Furukawa A; Aikawa Y; Kuroda O; Niizato K; Izawa R; Nakamura K; Mori N; Matsuzawa D; Hashimoto K; Iyo M; Sora I; Matsushita M; Okazaki Y; Yoshikawa T; Miyata T; Itokawa M
    Arch Gen Psychiatry; 2010 Jun; 67(6):589-97. PubMed ID: 20530008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritis.
    Wang J; Guan Z; Ge Z
    Biomarkers; 2013 Mar; 18(2):155-9. PubMed ID: 23327497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid in synovial fluid and serum of patients with rheumatoid arthritis, spondyloarthropathy, and osteoarthritis.
    Parada-Turska J; Zgrajka W; Majdan M
    J Rheumatol; 2013 Jun; 40(6):903-9. PubMed ID: 23588943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.